Recurrent toxic epidermal necrolysis with two different drugs in a patient with chronic kidney disease-A case report with an atypical presentation

被引:0
作者
Mathur, Mahesh [1 ]
Thakur, Neha [1 ]
Jaiswal, Sunil [1 ]
Maharjan, Srijana [1 ]
Paudel, Supriya [1 ]
Shrestha, Anjali [1 ]
机构
[1] Coll Med Sci & Teaching Hosp, Dept Dermatol Venereol & Leprol, Bharatpur, Nepal
来源
CLINICAL CASE REPORTS | 2023年 / 11卷 / 10期
关键词
chronic kidney disease; cross-reactivity; recurrent toxic epidermal necrolysis;
D O I
10.1002/ccr3.8027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Toxic epidermal necrolysis (TEN) is a dermatologic emergency usually attributed to drugs. Recurrent episodes of TEN are more common in the pediatric population than in adults. Patients carrying susceptible specific haplotypes, cross-reactivity between the drugs, and drug metabolites generated by the Cytochrome P450 are the key factors for the recurrent episodes. Chronic kidney disease (CKD) increases the risk of toxic epidermal necrolysis by altering the pharmacokinetics and pharmacodynamics of the drug with comparatively higher mortality in this group of patients. We hereby present an elderly female with 2 episodes of TEN following intake of furosemide at present and Nimesulide 3 years back. Cross-reactivity between these drugs because of the similar stereochemical structure might have triggered the second episode. The second episode of TEN was milder in presentation with a short latency period without any constitutional symptoms as compared to the first episode. Thus, treating physicians should always consider cross-reactivity between the chosen drugs in order to prevent subsequent life-threatening episodes, especially in patients with CKD.
引用
收藏
页数:4
相关论文
共 9 条
  • [1] [Anonymous], 2023, PubChem Compound Summary for CID 4539
  • [2] Drateln CR., 2016, Drug Saf Case Rep, V3, P1
  • [3] Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective
    Gupta, Lalit Kumar
    Martin, Abhay Mani
    Agarwal, Nidheesh
    D'Souza, Paschal
    Das, Sudip
    Kumar, Rajesh
    Pande, Sushil
    Das, Nilay Kanti
    Kumaresan, Muthuvel
    Kumar, Piyush
    Garg, Anubhav
    Singh, Saurabh
    [J]. INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2016, 82 (06) : 603 - 625
  • [4] Toxic epidermal necrolysis and Stevens-Johnson syndrome
    Harr, Thomas
    French, Lars E.
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2010, 5
  • [5] Acute Renal Failure and Its Risk Factors in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Hung, Chi-Chih
    Liu, Wan-Chun
    Kuo, Mei-Chuan
    Lee, Chih-Hung
    Hwang, Shang-Jyh
    Chen, Hung-Chun
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (06) : 633 - 638
  • [6] Kinoshita Yuri, 2016, J Nippon Med Sch, V83, P216, DOI 10.1272/jnms.83.216
  • [7] Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
    Levey, AS
    Eckardt, KU
    Tsukamoto, Y
    Levin, A
    Coresh, J
    Rossert, J
    de Zeeuw, D
    Hostetter, TH
    Lameire, N
    Eknoyan, G
    [J]. KIDNEY INTERNATIONAL, 2005, 67 (06) : 2089 - 2100
  • [8] National Center for Biotechnology Information, 2023, PubChem Compound Summary for CID 2474
  • [9] Epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States and factors predictive of outcome
    Wasuwanich, Paul
    So, Joshua M.
    Chakrala, Teja S.
    Chen, Jinghua
    Motaparthi, Kiran
    [J]. JAAD INTERNATIONAL, 2023, 13 : 17 - 25